M. A. Halim Khan

Cardiovascular-kidney-metabolic syndrome: Beyond glycemic control

Diabetes is a chronic, progressive disease requiring durable, evidence-based therapies that address glycaemic control and broader cardiometabolic risk. Originator molecules play a key role in this landscape, supported by extensive clinical development, rigorous quality standards, established safety monitoring, and long...